Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

VirnetX Holding (VHC) Research & Development (2016 - 2026)

VirnetX Holding's Research & Development history spans 17 years, with the latest figure at $1.2 million for Q1 2026.

  • On a quarterly basis, Research & Development fell 7.7% to $1.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was $5.6 million, a 7.83% decrease, with the full-year FY2025 number at $5.7 million, down 6.36% from a year prior.
  • Research & Development came in at $1.2 million for Q1 2026, down from $2.0 million in the prior quarter.
  • The five-year high for Research & Development was $4.8 million in Q2 2023, with the low at $1.1 million in Q3 2025.
  • Historically, Research & Development has averaged $1.7 million across 5 years, with a median of $1.3 million in 2022.
  • Biggest five-year swings in Research & Development: soared 278.88% in 2023 and later crashed 74.28% in 2024.
  • Year by year, Research & Development stood at $2.7 million in 2022, then decreased by 12.41% to $2.4 million in 2023, then fell by 0.04% to $2.4 million in 2024, then fell by 14.09% to $2.0 million in 2025, then tumbled by 42.96% to $1.2 million in 2026.
  • Business Quant data shows Research & Development for VHC at $1.2 million in Q1 2026, $2.0 million in Q4 2025, and $1.1 million in Q3 2025.